Product Center
Products Center
Jiuhua Huayuan Pharmaceutical's drug surveillance work has been awarded national recognition
Release time:
2025-03-26 00:00
Source:
Recently, the National Adverse Drug Reaction Monitoring Center issued a notice to commend units that have performed outstandingly in the 2024 national adverse drug reaction monitoring and evaluation work. Jiuhua Huayuan Pharmaceutical Co., Ltd. has been awarded national recognition for its outstanding performance in drug surveillance system construction, monitoring and evaluation management, and implementation of main responsibilities, becoming the only drug listing holder in Anhui Province to receive this honor.
Drug safety is closely related to people's health and has always been the primary responsibility of Jiuhua Huayuan Pharmaceutical. The company strictly implements the Drug Administration Law and the Quality Management Standards for Drug Vigilance, continuously deepens the construction of the drug surveillance system, strengthens the training of internal monitoring teams, enhances the ability to monitor adverse reactions, and ensures the safety and effectiveness of every product. With solid drug surveillance work, the company was recommended as one of the first holder drug surveillance sentinel monitoring units in Anhui Province in 2024, and shared relevant experience at provincial training conferences to help improve the overall regulatory level of the industry.
As a leading pharmaceutical company in the industry, we always adhere to our original intention and fulfill the main responsibility of drug marketing authorization holders with a scientific and rigorous attitude. The company continuously promotes the development of drug surveillance work towards greater precision and efficiency by establishing a sound monitoring data management system, optimizing the mechanism for collecting adverse reaction reports, and enhancing drug risk assessment capabilities. This national recognition is a recognition of the company's long-term adherence to high standards and strict requirements in drug safety management, and also the best testimony to the joint efforts of all employees.
In the future, we will continue to fulfill our drug surveillance responsibilities with higher standards, fully leverage the exemplary and leading role of sentinel units, actively explore diversified monitoring methods, continuously improve our drug safety risk warning and prevention capabilities, assist in the high-quality development of the industry, and provide safer and more reliable pharmaceutical products for patients. Jiuhua Huayuan Pharmaceutical will never forget its original intention, forge ahead, safeguard public health with technological innovation and responsibility, and contribute greater strength to the "Healthy China" strategy!
